Legato Capital Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.22K | Sell |
14,005
-690
| -5% | -$306 | ﹤0.01% | 562 |
|
|
2025
Q1 | $8.32K | Hold |
14,695
| – | – | ﹤0.01% | 563 |
|
|
2024
Q4 | $31K | Sell |
14,695
-21,730
| -60% | -$45.9K | ﹤0.01% | 561 |
|
|
2024
Q3 | $98K | Hold |
36,425
| – | – | 0.01% | 538 |
|
|
2024
Q2 | $104K | Buy |
36,425
+1,397
| +4% | +$3.98K | 0.01% | 538 |
|
|
2024
Q1 | $149K | Buy |
35,028
+3,011
| +9% | +$12.8K | 0.02% | 538 |
|
|
2023
Q4 | $171K | Hold |
32,017
| – | – | 0.02% | 535 |
|
|
2023
Q3 | $138K | Sell |
32,017
-17,788
| -36% | -$76.5K | 0.02% | 522 |
|
|
2023
Q2 | $273K | Sell |
49,805
-17,990
| -27% | -$98.8K | 0.04% | 489 |
|
|
2023
Q1 | $285K | Hold |
67,795
| – | – | 0.05% | 418 |
|
|
2022
Q4 | $188K | Buy |
+67,795
| New | +$188K | 0.04% | 456 |
|